CapsoVision Inc reports results for the quarter ended June 30 - Earnings Summary

CapsoVision

13/08/2026 22:01

CapsoVision Inc CV.OQ reported a quarterly adjusted loss of 15 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-2.02.  The lone analyst forecast for the quarter was for a loss of 13 cents per share. 
Revenue rose 9.9% to $3.64 million from a year ago; analysts expected $3.81 million. 
CapsoVision Inc's reported EPS for the quarter was a loss of 15 cents​.
The company reported a quarterly loss of $7.48 million.
CapsoVision Inc shares had fallen by 9.5% this quarter and lost 35.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 8.3% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for CapsoVision Inc is $10.00, about 31.4% above its last closing price of $6.86
This summary was machine generated from LSEG data August 13 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.13
-0.15
Missed
Mar. 31 2026 
-0.13
-0.15
Missed
Dec. 31 2025 
-0.14
-0.02
Beat
Sep. 30 2025 
-0.12
-0.17
Missed